Naratriptan
Product manufactured by Orchidpharma, Inc
Indications and Purposes
| 1 Indications And Usage Naratriptan Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Naratriptan Tablets, Reconsider The Diagnosis Of Migraine Before Naratriptan Tablets Are Administered To Treat Any Subsequent Attacks. Naratriptan Tablets Are Not Indicated For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Naratriptan Tablets Have Not Been Established For Cluster Headache. Naratriptan Tablets Are A Serotonin (5-Ht 1b/1d ) Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. (1) Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. (1) Not Indicated For The Prophylactic Therapy Of Migraine Attacks. (1) Not Indicated For The Treatment Of Cluster Headache. (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Naratriptan Hydrochloride |
|
ZINC4076 |